Innoviva Stock Price on November 12, 2024
| INVA Stock | USD 19.05 0.09 0.47% |
Below is the normalized historical share price chart for Innoviva extending back to October 05, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Innoviva stands at 19.05, as last reported on the 28th of November, with the highest price reaching 19.20 and the lowest price hitting 18.95 during the day.
If you're considering investing in Innoviva Stock, it is important to understand the factors that can impact its price. Innoviva holds Efficiency (Sharpe) Ratio of -0.0187, which attests that the entity had a -0.0187% return per unit of risk over the last 3 months. Innoviva exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Innoviva's insignificant Market Risk Adjusted Performance, downside deviation of 1.24, and Risk Adjusted Performance of 0.004 to validate the risk estimate we provide.
At present, Innoviva's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 1.3 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 81.9 M. . At present, Innoviva's Price Earnings Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 1.63, whereas Price To Sales Ratio is forecasted to decline to 3.21. Innoviva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of October 2004 | 200 Day MA 17.2441 | 50 Day MA 19.5718 | Beta 0.568 |
Innoviva |
Sharpe Ratio = -0.0187
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INVA |
Estimated Market Risk
| 1.11 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Innoviva is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innoviva by adding Innoviva to a well-diversified portfolio.
Price Book 1.7922 | Enterprise Value Ebitda 11.2693 | Price Sales 3.3967 | Shares Float 50.4 M | Wall Street Target Price 19 |
Related Headline
Terns Pharmaceuticals Headline on 12th of November 2024
Terns Pharmaceuticals Reports Third Quarter 2024 Financial R... by finance.yahoo.com
Interim data from initial dose escalation cohorts of Phase 1 CARDINAL trial evaluating TERN-701 in chronic myeloid leukemia expected in early December 2024 Plans to initiate Phase 2 clinical trial for TERN-601 in obesity in early 2Q25 with initial 12-week data expected in 2H25 Cash, cash equivalents and marketable securities of 372.8 million, including 172.7 million equity raise in September, expected to provide runway into 2028 FOSTER CITY,
Innoviva Valuation on November 12, 2024
It is possible to determine the worth of Innoviva on a given historical date. On November 12, 2024 Innoviva was worth 20.1 at the beginning of the trading date compared to the closed value of 20.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Innoviva stock. Still, in general, we apply an absolute valuation method to find Innoviva's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Innoviva where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Innoviva's related companies.
| Open | High | Low | Close | Volume | |
| 20.25 | 20.32 | 20.06 | 20.12 | 518,781 | |
11/12/2024 | 20.10 | 21.28 | 19.97 | 20.32 | 2,331,044 |
| 21.24 | 21.26 | 20.05 | 20.10 | 679,148 |
| Backtest Innoviva | | | Innoviva History | | | Innoviva Valuation | Previous | Next |
Innoviva Trading Date Momentum on November 12, 2024
| On November 13 2024 Innoviva was traded for 20.10 at the closing time. The top price for the day was 21.26 and the lowest listed price was 20.05 . The trading volume for the day was 679.1 K. The trading history from November 13, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.08% . The trading delta at closing time against the current closing price is 6.05% . |
Innoviva Fundamentals Correlations and Trends
By evaluating Innoviva's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Innoviva's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Innoviva financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Innoviva Stock history
Innoviva investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Innoviva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Innoviva will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Innoviva stock prices may prove useful in developing a viable investing in Innoviva
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 86.9 M | 81.9 M | |
| Net Income Applicable To Common Shares | 246 M | 258.3 M |
Innoviva Quarterly Net Working Capital |
|
Innoviva Stock Technical Analysis
Innoviva technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Innoviva Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Innoviva cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Innoviva November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Innoviva stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Innoviva shares will generate the highest return on investment. By undertsting and applying Innoviva stock market strength indicators, traders can identify Innoviva entry and exit signals to maximize returns
Innoviva Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Innoviva's price direction in advance. Along with the technical and fundamental analysis of Innoviva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Innoviva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.004 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | (0.10) | |||
| Treynor Ratio | (0.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Innoviva Stock analysis
When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |